Toth Financial Advisory’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.42K Sell
15
-22
-59% -$3.67K ﹤0.01% 767
2026
Q2
$7.02K Hold
37
– – ﹤0.01% 619
2026
Q1
$7.3K Buy
37
+28
+311% +$5.4K ﹤0.01% 597
2025
Q4
$1.66K Buy
+9
New +$1.58K ﹤0.01% 735

Other funds holding AZN

Toth Financial Advisory's AZN Position: Q3 2026 in Review

Toth Financial Advisory reduced its AstraZeneca (AZN) stake by 59% in Q3 2026, selling an estimated $3.67K and leaving 15 shares worth $2.42K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

Toth Financial Advisory first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.3K in Q1 2026. 1,441 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Toth Financial Advisory held 15 shares of AstraZeneca worth $2.42K as of Q3 2026.
  • Toth Financial Advisory sold 22 AstraZeneca shares in Q3 2026, an estimated $3.67K.
  • AstraZeneca made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #767 holding.
  • Toth Financial Advisory first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • Toth Financial Advisory's AstraZeneca position peaked at $7.3K in Q1 2026.
  • 1,441 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.